For the reason that folks who carry the APOE e4 gene variant seem to have a greater danger of serious complications, the FDA recommends getting tested to the gene variant before beginning treatment with lecanemab or donanemab. The test is used To judge early signs of dementia (the progressive loss https://mitcha974veo4.izrablog.com/profile